Published in Acta Obstet Gynecol Scand on February 17, 2015
Nutritional Markers in Normal and Hyperemesis Pregnancies (PUQE-M) | NCT02619188
Immunology of hepatic diseases during pregnancy. Semin Immunopathol (2016) 0.78
Barriers and Challenges in Hyperemesis Gravidarum Research. Nutr Metab Insights (2016) 0.77
Hyperemesis Gravidarum is associated with substantial economic burden in addition to severe physical and psychological suffering. Isr J Health Policy Res (2016) 0.75
Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding). BMC Pregnancy Childbirth (2016) 0.75
Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc Natl Acad Sci U S A (2008) 3.30
Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet (2011) 1.84
Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit. BMJ (2002) 1.66
Markers for individualised therapy in endometrial carcinoma. Lancet Oncol (2012) 1.61
Intensive care diaries reduce new onset post traumatic stress disorder following critical illness: a randomised, controlled trial. Crit Care (2010) 1.52
Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. Clin Cancer Res (2013) 1.21
SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer. Eur J Cancer (2011) 1.19
Multiple organ failure after trauma affects even long-term survival and functional status. Crit Care (2007) 1.13
Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer. Clin Cancer Res (2011) 1.03
Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. PLoS One (2013) 1.02
Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. Cancer Epidemiol Biomarkers Prev (2012) 1.02
High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. Clin Cancer Res (2013) 0.97
Time trends in incidence, etiology, and case fatality rate of the first attack of acute pancreatitis. Scand J Gastroenterol (2011) 0.96
Metabolic alkalosis is the most common acid-base disorder in ICU patients. Crit Care (2014) 0.93
Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Res (2011) 0.93
High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. PLoS One (2012) 0.91
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. Am J Obstet Gynecol (2009) 0.90
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Hum Genet (2014) 0.89
Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. Cancer (2013) 0.89
Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists. Eur Radiol (2012) 0.88
Follow-up after intensive care: a single center study. Intensive Care Med (2003) 0.88
Evolution in endometrial cancer: evidence from an immunohistochemical study. Int J Gynecol Cancer (2011) 0.87
Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol (2013) 0.87
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer (2014) 0.87
Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. Eur Radiol (2013) 0.86
The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium: a collaborative study. Int J Gynecol Cancer (2011) 0.85
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Mod Pathol (2012) 0.84
Changes in intensive care from 1987 to 1997 - has outcome improved? A single centre study. Intensive Care Med (2002) 0.84
MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk. PLoS One (2012) 0.84
Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. Gynecol Oncol (2012) 0.84
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. Oncotarget (2014) 0.82
Changes in health-related quality of life from 6 months to 2 years after discharge from intensive care. Health Qual Life Outcomes (2003) 0.82
Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome. Acta Obstet Gynecol Scand (2003) 0.82
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. Int J Gynecol Cancer (2015) 0.81
Polymorphisms in inflammation pathway genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev (2012) 0.81
Long-term survival and quality of life after intensive care for patients 80 years of age or older. Ann Intensive Care (2015) 0.80
Impact of night shifts on laparoscopic skills and cognitive function among gynecologists. Acta Obstet Gynecol Scand (2014) 0.80
Long-Term Outcomes After ICU Admission Triage in Octogenarians. Crit Care Med (2017) 0.79
Reversible dyscognition in patients with a unilateral, middle fossa arachnoid cyst revealed by using a laptop based neuropsychological test battery (CANTAB). J Neurol (2010) 0.79
Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. Histopathology (2011) 0.79
Plasma calprotectin concentrations in women with endometrial carcinoma. Gynecol Oncol (2009) 0.78
Sexual function in ICU survivors more than 3 years after major trauma. Intensive Care Med (2007) 0.78
Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer. Histopathology (2010) 0.77
Impact of reimbursement schemes on quality of care: a European perspective. Am J Respir Crit Care Med (2012) 0.76
[Physicians with limits]. Tidsskr Nor Laegeforen (2013) 0.75
[Metabolic acidosis--not always easy]. Tidsskr Nor Laegeforen (2013) 0.75
Chronotypes, night shifts and intensive care. Intensive Care Med (2015) 0.75
[Not "just" morning sickness]. Tidsskr Nor Laegeforen (2014) 0.75
[Outcome after intensive care]. Tidsskr Nor Laegeforen (2010) 0.75
Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth. Sci Rep (2016) 0.75
[Quantification of morning sickness]. Tidsskr Nor Laegeforen (2015) 0.75
[Reduction of ventilator time by systematic quality work]. Tidsskr Nor Laegeforen (2003) 0.75
[Staffing and emergency service in Norwegian obstetrics and gynecology departments]. Tidsskr Nor Laegeforen (2004) 0.75
[Uro- and enterovaginal fistulas]. Tidsskr Nor Laegeforen (2007) 0.75
Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth. Sci Rep (2017) 0.75
[Severe sepsis treated with activated protein C]. Tidsskr Nor Laegeforen (2004) 0.75